Abstract |
After a lengthy search for an effective treatment for resected pancreatic cancer, evidence accumulated in the past 10 years shows that adjuvant chemotherapy is firmly established as offering a modest but real improvement in overall survival. However, the optimal choice of treatment modality ( chemotherapy with or without radiation therapy) remains highly controversial. Results from ongoing studies will further optimize the treatment over the next decade.
|
Authors | Tomoo Kosuge, Yoshihiro Sakamoto, Hideki Ueno |
Journal | Journal of hepato-biliary-pancreatic sciences
(J Hepatobiliary Pancreat Sci)
Vol. 18
Issue 6
Pg. 792-6
(Nov 2011)
ISSN: 1868-6982 [Electronic] Japan |
PMID | 21874279
(Publication Type: Journal Article, Review)
|
Copyright | © 2011 Japanese Society of Hepato-Biliary-Pancreatic Surgery. |
Topics |
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Humans
- Pancreatic Neoplasms
(therapy)
- Radiotherapy, Adjuvant
- Treatment Outcome
|